FWP: - 5.59, $0.00M, -0.06 (-1.06%)

Sector: Healthcare - Industry: Biotechnology

Forward Pharma A/S operates as a biopharmaceutical company. The company engages in developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.Key Statistics

Past FWP reports

Earning Date	Time	Title	EPS-e	EPS-a	Close	Prev Close	Open	Day Low	Day High	Gap %	CFO %	Change %	Volume
2016-11-25			-0.38							▲
2016-11-24			-0.38		22.74	22.09	21.8	20.48	22.74	-1.31%▲	4.31%	2.94%	7.74K
2016-11-23			-0.38		22.09	22.09	20.99	20.99	22.48	-4.98%▲	5.24%		12.50K
2016-09-01			-0.26		19.13	19.08	19.31	19.06	20.77	1.21%	-0.93%	0.26%	9.68K
2016-05-13			-0.27
2016-05-12			-0.27		18.2	17.5	17.5		18.66		4.00%	4.00%	7.96K
2016-05-11			-0.27		17.5	18.72	18.71	17.21	19.25	-0.05%	-6.47%	-6.52%	22.20K
2016-05-10			-0.27		18.72	19.1	18.91	17.69	19.12	-0.99%	-1.00%	-1.99%	6.02K
2016-03-25			-0.38
2016-03-24			-0.38		16.43	16.8	16.67	15.8	17.01	-0.77%	-1.44%	-2.20%	29.12K
2016-03-23			-0.38		16.43	16.8	16.67	15.8	17.01	-0.77%	-1.44%	-2.20%	29.12K
2015-11-25			-0.32		22.15	20.53	20.5	20.5	22.25	-0.15%▲	8.05%	7.89%	32.98K
2015-05-12			-0.19		34.05	34.15		33.54	34.83			-0.29%	75.38K
2015-03-25			-0.27		24.03	23.25	23.01	22.27	24.27	-1.03%	4.43%	3.35%	30.76K